Remus Vezan

2.3k citations
17 papers · 238 indexed · h-index 9
Topics
CAR-T cell therapy research (10 papers)Acute Lymphoblastic Leukemia research (5 papers)Histone Deacetylase Inhibitors Research (3 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood

In The Last Decade

Remus Vezan

16 papers receiving 235 citations

Peers

Remus Vezan
Comparison fields: 5 of 35
  • Oncology 161
  • Molecular Biology 95
  • Pathology and Forensic Medicine 67
  • Genetics 42
  • Immunology 35
Replace Boyu Hu with:
Boyu Hu United States
Paolo Strati United States
Ahmed Galal United States
Sandrine Montheard United States
Kathleen Ruehle United States
Patricia Steinert United States
Jan J. Melenhorst United States
Erin Mullane United States
Misha Hawkins United States
Florian Eisele Germany
Remus Vezan relative to Boyu Hu United States Boyu Hu's profile →
Citations per field
00.5×11×
Boyu Hu · 1×
Citations per year

Countries citing papers authored by Remus Vezan

Since Specialization
Citations

This map shows the geographic impact of Remus Vezan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Remus Vezan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Remus Vezan more than expected).

Fields of papers citing papers by Remus Vezan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Remus Vezan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Remus Vezan. The network helps show where Remus Vezan may publish in the future.

Co-authorship network of co-authors of Remus Vezan

This figure shows the co-authorship network connecting the top 25 collaborators of Remus Vezan. A scholar is included among the top collaborators of Remus Vezan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Remus Vezan. Remus Vezan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 0
2 1
3 4
4 26
5 1
6 43
7 1
8 8
9 29
10 1
11 1
12 8
13 8
14 71
15 11
16 15
17 10

About Remus Vezan

Remus Vezan is a scholar working on Oncology, Hematology and Immunology, having authored 17 papers that have together received 238 indexed citations. Recurring topics across this work include CAR-T cell therapy research (10 papers), Acute Lymphoblastic Leukemia research (5 papers) and Histone Deacetylase Inhibitors Research (3 papers). The work is most often cited by research in Oncology (161 citations), Pathology and Forensic Medicine (67 citations) and Genetics (32 citations). Remus Vezan has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Ioana Kloos, Ying Luan, Thorsten Graef, Won Seog Kim, Franck Morschhauser, Réda Bouabdallah, Bertrand Coiffier, John M. Rossi, Soon Thye Lim and Vincent Ribrag. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026